<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Basu S</submitter><funding>NCRR NIH HHS</funding><funding>NIDDK NIH HHS</funding><pagination>1140-1148</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7968436</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>39(7)</volume><pubmed_abstract>Sugar-sweetened beverages (SSBs) increase chronic disease risk. We estimated the impact on employee health and health care spending of banning SSB sales in California-based health care organizations. We used survey data from a large, multisite health care organization in California, sampling 2,276 employees three months before and twelve months after a workplace SSB sales ban was imposed. We incorporated the survey data into a simulation model to estimate chronic disease incidence and costs. We estimated that an SSB ban as effective as the one observed would save about $300,000 per 10,000 people over ten years among similar employers, as a result of averted health care and productivity spending-after both SSB sales losses and non-SSB beverage sales gains were accounted for. Sales bans woul</pubmed_abstract><journal>Health affairs (Project Hope)</journal><pubmed_title>Cost-Effectiveness Of A Workplace Ban On Sugar-Sweetened Beverage Sales: A Microsimulation Model.</pubmed_title><pmcid>PMC7968436</pmcid><funding_grant_id>P30 DK092924</funding_grant_id><funding_grant_id>R01 DK116852</funding_grant_id><funding_grant_id>M01 RR001271</funding_grant_id><funding_grant_id>P30 DK098722</funding_grant_id><pubmed_authors>Schillinger D</pubmed_authors><pubmed_authors>Schmidt L</pubmed_authors><pubmed_authors>Basu S</pubmed_authors><pubmed_authors>Jacobs LM</pubmed_authors><pubmed_authors>Epel E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cost-Effectiveness Of A Workplace Ban On Sugar-Sweetened Beverage Sales: A Microsimulation Model.</name><description>Sugar-sweetened beverages (SSBs) increase chronic disease risk. We estimated the impact on employee health and health care spending of banning SSB sales in California-based health care organizations. We used survey data from a large, multisite health care organization in California, sampling 2,276 employees three months before and twelve months after a workplace SSB sales ban was imposed. We incorporated the survey data into a simulation model to estimate chronic disease incidence and costs. We estimated that an SSB ban as effective as the one observed would save about $300,000 per 10,000 people over ten years among similar employers, as a result of averted health care and productivity spending-after both SSB sales losses and non-SSB beverage sales gains were accounted for. Sales bans woul</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jul</publication><modification>2025-04-18T16:41:53.088Z</modification><creation>2025-04-07T04:07:08.103Z</creation></dates><accession>S-EPMC7968436</accession><cross_references><pubmed>32634357</pubmed><doi>10.1377/hlthaff.2019.01483</doi></cross_references></HashMap>